Marine Drugs (Sep 2014)

Purification of a Low Molecular Weight Fucoidan for SPECT Molecular Imaging of Myocardial Infarction

  • Pierre Saboural,
  • Frédéric Chaubet,
  • Francois Rouzet,
  • Faisal Al-Shoukr,
  • Rana Ben Azzouna,
  • Nadia Bouchemal,
  • Luc Picton,
  • Liliane Louedec,
  • Murielle Maire,
  • Lydia Rolland,
  • Guy Potier,
  • Dominique Le Guludec,
  • Didier Letourneur,
  • Cédric Chauvierre

DOI
https://doi.org/10.3390/md12094851
Journal volume & issue
Vol. 12, no. 9
pp. 4851 – 4867

Abstract

Read online

Fucoidans constitute a large family of sulfated polysaccharides with several biochemical properties. A commercial fucoidan from brown algae, containing low molecular weight polysaccharidic species constituted of l-fucose, uronic acids and sulfate groups, was simply treated here with calcium acetate solution. This treatment led to a purified fraction with a yield of 45%. The physicochemical characterizations of the purified fucoidan using colorimetric assay, MALLS, dRI, FT-IR, NMR, exhibited molecular weight distributions and chemical profiles similar for both fucoidans whereas the sulfate and l-fucose contents increased by 16% and 71%, respectively. The biodistribution study in rat of both compounds labeled with 99mTc evidenced a predominant renal elimination of the purified fucoidan, but the crude fucoidan was mainly retained in liver and spleen. In rat myocardial ischemia-reperfusion, we then demonstrated the better efficiency of the purified fucoidan. This purified sulfated polysaccharide appears promising for the development of molecular imaging in acute coronary syndrome.

Keywords